Bioarrays for Life Science Research, Diagnostics and Drug R&D

Publication Date	August 2009
Publisher	Takeda Pacific
Product Type	Report
Pages	177
ISBN Number	not applicable
Product Code	TKD00009

Buy this product or for assistance call +44 20 7060 7474

PDF £1,500.00$2495 | €1679

FAX Order above formats by FAX

Summary

This research report is about the worldwide bioarray tools, technologies and services market. Bioarrays are also known as DNA microarrays, protein arrays, or biochips. These key mainstream life science research products and services involve technologies that scientists use to detect and analyze genetic and protein material such as DNA, RNA, proteins, antibodies, stem cells, tissues, biomarkers and so on. This study takes into account the impact of key economic factors influencing this industry including the severe global recession of 2008-2009, pharmaceutical industry structural changes, the potential effect of government stimulus programs on life science research, ideas about healthcare reform and more.

This report discusses new bioarray products reaching the market including DNA and RNA products such as high-density arrays, tiling, copy number variation, SNPs, alternate splice variant arrays, ChIP-Chip, CpG island, DNA methylation, microRNA, sequence-capture arrays for targeted resequencing, array-based molecular diagnostics and related areas. The study reviews microfluidic bioarrays such as for POC diagnostics through credit card-sized devices, for liquid chromatography, or for drug discovery optimization. This study also discusses commercial developments in protein bioarrays and SPR biosensors.

The study shows that bioarray product and service vendors are navigating a challenging market. Takeda Pacific's report discusses the major areas of this dynamic market landscape. This report shows various views of this growing multi-billion dollar market. The report estimates that over its five-year forecast that the bioarray product and services market would reach a high single-digit growth rate (CAGR). The report charts the developments of numerous companies involved in this rapidly changing and evolving industry.

This broad study provides interesting data and includes more than 64 tables and figures. The tables include data about technologies, companies, future product roadmaps, and more. The report presents partnering deals and includes several years of alliance and M&A data. The report reviews twenty-four selected companies, with details including contact information, business and product overviews, alliances and patents or other details. This fully searchable PDF report helps busy readers save time. This report uses hyperlinks to help readers jump to Table of Content items or to text-linked Internet sites.

This must-have report would benefit people with job titles including CEO, VPs, Director of Business Development, Research Directors, Entrepreneurs, Venture Capitalists, Investment Planners, Research Scientists, Consultants or Industry Analysts.

Content

1. Market Overview
The Dynamic and Evolving Bioarray Industry
WW Bioarray Market Size and Forecasts: Total and Key Segments
Bioarray Market Trends
Bioarray Trends and Directions
Technology Trends
Next Generation Technology
Product Innovations and Developments
Company Activities in Array-based Diagnostics

2. Genetic Bioarray Products & Services
Genetic Bioarray Products by Segments
Strategic Alliances and M&As by Segments
Products by Segments
Bioarray Supply Chain
Patents by Product Segments
Vendor Growth and Analysis by Product Segments
Worldwide Genetic Bioarray Market Size and Forecast to 2013
Methodology
Revenue Review
Market Shares of Major Commercial Vendors by Segments
The Current Status and Future Outlook by Segments
Price Trends
Sales and Distribution Roadmap
Healthcare Issues
Next Generation Bioarray Technology Roadmap
Genetic Bioarray Service Provider Roadmap
Current & Future Service Providers
WW Bioarray Service Provider Market Size & Forecast to 2013
Market Share of the Independent Service Providers
Current and Future: Service Provider's Roadmap

3. Protein Bioarrays and Instruments
Current Status by Product Segments
Strategic Alliances by Product Segments
Current & Future Products by Segments
Protein Bioarray Supply Chain
Patents by the Product Segment
Company Growth of Protein Bioarray Vendors by Segment
WW Protein Bioarray Market Size and Forecast to 2013
Market Shares of Leading Protein Bioarray Vendors
The Current Status and Future Outlook by Product Segments
Price Trends
Sales and Distribution Roadmap
Healthcare Issues
Next Generation Technology Roadmap

4. Microfluidic Bioarrays and Instruments
Leading Vendor Status by Revenues
Strategic Alliances and M&As by Date
Current & Future Microfluidic Bioarray Products by Segments
Microfluidic Bioarray Vendor Supply Chain
Patents of Microfluidic Bioarray Vendors by Segment
Growth & Analysis of Microfluidic Bioarray Vendors by Segment
Worldwide Market Size and Forecast to 2013
Market Shares of Major Microfluidic Bioarray Vendors by Segment
Current Status and Future Outlook by Product Segments
Product Price Trends
Sales and Distribution Roadmap
Healthcare Issues
Next Generation Technology Roadmap

5. Activities of Selected Bioarray Companies
Affymetrix, Inc.
Agilent Technologies, Inc., BAM
Applied Microarrays, Inc.
ArrayIt Corporation
Biolog, Inc.
BioMicro Systems, Inc.
Bio-Rad Laboratories, Inc.
Caliper Life Sciences, Inc.
CapitalBio Corporation
CombiMatrix Corporation
Eppendorf AG
Expression Analysis, Inc.
Fluidigm Corporation
GenTel BioSciences, Inc.
GWC Technologies, Inc.
Illumina, Inc.
Life Technologies, Inc.
Ocimum Biosolutions, Inc.
Oxford Gene Technology Ltd.
SABiosciences Corporation
SciGene Corporation
Sequenom, Inc.
Sigma-Aldrich Corporation
Tecan Group AG

6. Findings and High Growth Areas
Major Findings
Impact of Major Economic Factors and Political Change
High-Density Whole Genome Bioarrays
Market Expansion and Transitions to New Areas
Bioarray-Based Diagnostics
FDA's MAQC and Commercial Bioarrays
Bioarray Demand Shifting to Asia
Bioarray Standardization Efforts
High-Throughput and Low to Mid- Multiplex Bioarray Analysis
Automated Microfluidic Bioarray Systems
Protein Bioarrays
Drug Safety, Genetic Variation and Bioarrays
Top Growth Opportunities for Bioarray Products
New Business Opportunities for Companies
Molecular Diagnostics
Consider Government/ Academic Customer Markets
Consider Agricultural/Bio Markets
Consider Other WW Regions for Cost Savings or New Customers
Target Marketing Efforts into Asia to Expand Business Opportunities
Opportunities in Asia
A Leading Customer and Resource Region
The Ocimum Model to Grow Globally

7. Appendix
Company Contact Information by Categories
About Takeda Pacific
About the Authors